| 000 | 01751 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515005709.0 | ||
| 264 | 0 | _c20060215 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0897-7151 | ||
| 024 | 7 |
_a10.1089/neu.2005.22.1362 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMihara, Kayoko | |
| 245 | 0 | 0 |
_aProhemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonist. _h[electronic resource] |
| 260 |
_bJournal of neurotrauma _cNov 2005 |
||
| 300 |
_a1362-73 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAspirin _xpharmacology |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 |
_aCollagenases _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 |
_aHeparin _xpharmacology |
| 650 | 0 | 4 |
_aIntracranial Hemorrhages _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPropionates _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xpharmacology |
| 650 | 0 | 4 | _aWhole Blood Coagulation Time |
| 700 | 1 | _aAoki, Toshiaki | |
| 700 | 1 | _aMoriguchi, Akira | |
| 700 | 1 | _aMaeda, Masashi | |
| 700 | 1 | _aFuruichi, Yasuhisa | |
| 700 | 1 | _aMatsuoka, Nobuya | |
| 700 | 1 | _aMutoh, Seitaro | |
| 773 | 0 |
_tJournal of neurotrauma _gvol. 22 _gno. 11 _gp. 1362-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/neu.2005.22.1362 _zAvailable from publisher's website |
| 999 |
_c15928648 _d15928648 |
||